Fera Taking Loss Over Thyroid Drug Generic To Fed. Circ.
By Dani Kass ( October 18, 2016, 3:26 PM EDT) -- Fera Pharmaceuticals LLC on Tuesday told a New Jersey federal court that it will be asking the Federal Circuit to overturn the court's order barring the drug company from making a generic of Fresenius Kabi USA LLC's levothyroxine-based thyroid medication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.